News

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...
What most saved lives, he said, were vaccines developed with unprecedented speed using mRNA technologies. "These vaccines really do work," Wohl, an infectious diseases professor who co-lead UNC's ...
The US health department's Biomedical Advanced Research and Development Authority is "terminating 22 mRNA vaccine development ...
The dollar fell against a basket of currencies, after President Trump said he would nominate Stephen Miran to temporarily join the Federal Reserve's board of governors. "Miran has expressed skepticism ...
Health and Human Services Secretary and long-time vaccine critic Robert F. Kennedy Junior’s decision to cancel $500 million ...
Fewer Kentucky kindergarten students have received the vaccines required to attend school, and data from the state's School ...
Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...
On Wednesday, after the news that the HHS was terminating crucial vaccine development projects worth $500 million, Cassidy called the decision "unfortunate" in a post on the X social network. That’s a ...
GSK said it would receive $370 million as part of a U.S. patent settlement between CureVac and BioNTech related to messenger mRNA-based Covid-19 vaccines.
Whether it’s county, state, or federal, trails in Pima County do not close, unlike in the Phoenix area. The Marana Town ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer ...